blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0696277

EP0696277 - HIV PROTEASE INHIBITORS USEFUL FOR THE TREATMENT OF AIDS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  18.04.1997
Database last updated on 13.07.2024
Most recent event   Tooltip18.04.1997Application deemed to be withdrawnpublished on 04.06.1997 [1997/23]
Applicant(s)For all designated states
Merck & Co., Inc.
126, East Lincoln Avenue P.O. Box 2000 Rahway
New Jersey 07065-0900 / US
[N/P]
Former [1996/07]For all designated states
MERCK & CO. INC.
126, East Lincoln Avenue P.O. Box 2000
Rahway New Jersey 07065-0900 / US
Inventor(s)01 / VACCA, Joseph, P.
766 Eisenhauer Drive
Telford, PA 18969 / US
02 / DORSEY, Bruce, D.
203 Continental Drive
Harleysville, PA 19438 / US
03 / GUARE, James, P.
1600 Kumry Road
Quakertown, PA 18951 / US
04 / HOLLOWAY, M., Katharine
171 Forest Trail Drive
Lansdale, PA 19446 / US
05 / HUNGATE, Randall, W.
1925 Rampart Lane
Lansdale, PA 19446 / US
06 / LEVIN, Rhonda, B.
5 Forsythia Court
Lafayette Hille, PA 19444 / US
[1996/07]
Representative(s)Cole, William Gwyn, et al
European Patent Department
Merck & Co., Inc.
Terlings Park
Eastwick Road
Harlow, Essex CM20 2QR / GB
[N/P]
Former [1996/07]Cole, William Gwyn, et al
European Patent Department Merck & Co., Inc. Terlings Park Eastwick Road
Harlow Essex CM20 2QR / GB
Application number, filing date94915427.226.04.1994
[1996/07]
WO1994US04621
Priority number, dateUS1993005903807.05.1993         Original published format: US 59038
[1996/07]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9426717
Date:24.11.1994
[1994/26]
Type: A1 Application with search report 
No.:EP0696277
Date:14.02.1996
[1996/07]
Search report(s)International search report - published on:EP24.11.1994
ClassificationIPC:C07D217/26, C07D241/04, C07D409/12, C07D401/06, C07D207/16, C07D401/12, C07C237/20, C07D409/06, A61K31/47, A61K31/495
[1996/07]
CPC:
C07D401/06 (EP,US); A61K31/70 (EP,US); A61K45/06 (EP,US);
A61P31/12 (EP); A61P31/18 (EP); A61P37/04 (EP);
C07C237/20 (EP,US); C07D207/16 (EP,US); C07D211/60 (EP,US);
C07D217/26 (EP,US); C07D241/04 (EP,US); C07D401/12 (EP,US);
C07D403/12 (EP,US); C07D405/06 (EP,US); C07D405/12 (EP,US);
C07D409/12 (EP,US); C07D417/12 (EP,US); C07C2602/08 (EP,US) (-)
C-Set:
A61K31/70, A61K2300/00 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1996/07]
Extension statesSI07.12.1995
TitleGerman:HIV PROTEASE INHIBITORS USEFUL FOR THE TREATMENT OF AIDS[1996/07]
English:HIV PROTEASE INHIBITORS USEFUL FOR THE TREATMENT OF AIDS[1996/07]
French:INHIBITEURS DE LA PROTEASE CODEE PAR LE VIH UTILES DANS LE TRAITEMENT DU SIDA[1996/07]
Entry into regional phase07.12.1995National basic fee paid 
07.12.1995Designation fee(s) paid 
07.12.1995Examination fee paid 
Examination procedure06.12.1994Request for preliminary examination filed
International Preliminary Examining Authority: EP
07.12.1995Examination requested  [1996/07]
31.05.1996Despatch of a communication from the examining division (Time limit: M06)
11.12.1996Application deemed to be withdrawn, date of legal effect  [1997/23]
10.01.1997Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [1997/23]
Fees paidRenewal fee
02.05.1996Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]EP0432695  (HOFFMANN LA ROCHE [CH]) [A] 1-7 *Page7,line 40 - page 8, line 50* *Page 11-17: claims*;
 [A]EP0434365  (MERCK & CO INC [US]) [A] 1-7 *Page 23, line 10 - page 34,line 30* *Page 83-101: claims*;
 [A]EP0492136  (AMERICAN CYANAMID CO [US]) [A] 1-7 *Page 59-71 : claims*;
 [A]EP0539192  (MERCK & CO INC [US]) [A] 1-7 *Page 27-29: claims*;
 [PA]EP0541168  (MERCK & CO INC [US]) [PA] 1-7*Document*
 [A]  - NOEL A. ROBERTS ET. AL., SCIENCE, (19900420), vol. 248, no. 4953, pages 358 - 361 [A] 1-7 *Document*
 [A]  - TERRY A. LYLE ET. AL., JOURNAL OF MEDICINAL CHEMISTRY, WASHINGTON, (199103), vol. 34, no. 3, pages 1228 - 1230 [A] 1-7 *Document*
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.